Medicare Enrolled
Dr. Raul Storey-Rojas, M.D.
Hematology & Oncology · Vero Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Storey-Rojas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Storey-Rojas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Storey-Rojas
Dr. Raul Storey-Rojas is a hematology & oncology specialist in Vero Beach, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Storey-Rojas performed 269,118 Medicare services across 9,452 unique beneficiaries.
Between the years covered by Open Payments, Dr. Storey-Rojas received a total of $26,580 from 96 pharmaceutical and/or device companies across 1404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Storey-Rojas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in FL
$26,580 industry payments
Medicare Practice Summary
Medicare Utilization ↗269,118
Medicare services
Top 1% in FL for hematology & oncology
9,452
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14,951 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
96,390 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 37,800 | $43 | $137 |
| Nivolumab injection (Opdivo) | 22,640 | $24 | $72 |
| Anti-nausea injection (aprepitant) | 14,560 | $1 | $5 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
11,600 | $0 | $12 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
9,000 | $0 | $5 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
8,640 | $38 | $110 |
| Denosumab injection (Prolia/Xgeva) | 8,580 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
7,951 | $6 | $23 |
| Paclitaxel chemotherapy injection | 7,950 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,768 | $8 | $29 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
3,432 | $26 | $116 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
3,359 | $8 | $9 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,086 | $0 | $3 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,910 | $6 | $22 |
| Iron infusion (Monoferric) | 2,600 | $16 | $57 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,204 | $36 | $108 |
| Injection, docetaxel, 1 mg | 1,916 | $0 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,857 | $97 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,810 | $1 | $28 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,660 | $0 | $1 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
1,554 | $4 | $113 |
| Injection, atropine sulfate, 0.01 mg | 1,280 | $0 | $1 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,279 | $23 | $185 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,019 | $11 | $69 |
| Injection, leucovorin calcium, per 50 mg | 836 | $3 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 748 | $0 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
632 | $102 | $378 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 625 | $3 | $205 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
601 | $4 | $10 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
567 | $12 | $61 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
560 | $2 | $8 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
485 | $2 | $7 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
453 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
303 | $50 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
295 | $66 | $239 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
286 | $82 | $297 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
244 | $23 | $84 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
234 | $1 | $3 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
230 | $2 | $41 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 219 | $134 | $562 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
210 | $22 | $79 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
207 | $2 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
173 | $51 | $178 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
169 | $25 | $156 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
148 | $7 | $69 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
138 | $26 | $89 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
128 | $8 | $51 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
128 | $17 | $59 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
121 | $127 | $453 |
| New patient office visit, complex (60-74 min) | 113 | $168 | $585 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
112 | $9 | $135 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
107 | $29 | $156 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
97 | $16 | $56 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
97 | $56 | $206 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
91 | $98 | $344 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
86 | $140 | $556 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
84 | $70 | $277 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
76 | $1 | $7 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
71 | $27 | $128 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
69 | $45 | $170 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
65 | $1 | $2 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
54 | $137 | $637 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
46 | $16 | $56 |
| Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg | 45 | $307 | $1,210 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
43 | $10 | $42 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
33 | $30 | $517 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
33 | $95 | $335 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $64 | $197 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $144 | $474 |
| Biofeedback training for bowel or bladder control, initial 15 minutes A 15-minute session using biofeedback techniques to help patients gain control over bowel or bladder functions. The training involves monitoring physiological processes to learn how to manage muscle activity. |
30 | $60 | $209 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
29 | $155 | $295 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
18 | $313 | $894 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
18 | $208 | $708 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
16 | $41 | $109 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
13 | $47 | $177 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $87 | $377 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
11 | $269 | $827 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
38.3% high complexity
57.4% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$26,580
Total received (2018-2024)
Avg $3,797/year across 7 years
Top 21% in FL for hematology & oncology
96
Companies
1,404
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,358 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$222 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,862
2023
$4,481
2022
$3,914
2021
$3,263
2020
$3,219
2019
$3,564
2018
$4,277
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$2,304
AstraZeneca Pharmaceuticals LP
$1,896
Janssen Biotech, Inc.
$1,832
Novartis Pharmaceuticals Corporation
$1,693
PFIZER INC.
$1,651
Celgene Corporation
$1,542
Amgen Inc.
$1,194
Incyte Corporation
$1,016
Lilly USA, LLC
$888
Merck Sharp & Dohme Corporation
$707
GENZYME CORPORATION
$699
Seagen Inc.
$680
Merck Sharp & Dohme LLC
$673
GlaxoSmithKline, LLC.
$643
Pharmacyclics LLC, An AbbVie Company
$624
Genentech USA, Inc.
$588
Bayer HealthCare Pharmaceuticals Inc.
$508
Daiichi Sankyo Inc.
$489
Astellas Pharma US Inc
$470
Gilead Sciences, Inc.
$361
Ipsen Biopharmaceuticals, Inc
$329
Eisai Inc.
$312
Foundation Medicine, Inc.
$307
TESARO, Inc.
$220
Alexion Pharmaceuticals, Inc.
$219
Takeda Pharmaceuticals U.S.A., Inc.
$213
Kite Pharma, Inc.
$212
Regeneron Healthcare Solutions, Inc.
$207
BeiGene USA, Inc.
$192
ARRAY BIOPHARMA INC
$170
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
EISAI INC.
$142
Dova Pharmaceuticals
$142
Pharmacyclics LLC, an AbbVie Company
$140
Axonics, Inc.
$137
AbbVie Inc.
$125
Karyopharm Therapeutics Inc.
$115
Bayer Healthcare Pharmaceuticals Inc.
$114
Puma Biotechnology, Inc.
$111
Boston Scientific Corporation
$109
ABBVIE INC.
$102
Kyowa Kirin, Inc.
$96
Stemline Therapeutics Inc.
$96
SERVIER PHARMACEUTICALS LLC
$95
Lexicon Pharmaceuticals, Inc.
$92
Taiho Oncology, Inc.
$91
Exelixis Inc.
$88
Deciphera Pharmaceuticals Inc.
$88
MorphoSys, US Inc.
$84
Seattle Genetics, Inc.
$82
PharmaEssentia USA Corporation
$81
TerSera Therapeutics LLC
$71
Clovis Oncology, Inc.
$68
Janssen Products, LP
$65
Myriad Genetic Laboratories, Inc.
$64
Heron Therapeutics, Inc.
$60
EMD Serono, Inc.
$55
JAZZ PHARMACEUTICALS INC.
$52
Blueprint Medicines Corporation
$51
G1 Therapeutics, Inc.
$48
SOBI, INC
$47
Adaptive Biotechnologies Corporation
$47
Sirtex Medical Inc
$46
Biocon Biologics Inc
$46
Aveo Pharmaceuticals, Inc.
$45
CSL Behring
$41
Shire North American Group Inc
$37
Advanced Accelerator Applications
$36
Global Blood Therapeutics, Inc.
$36
Agios Pharmaceuticals, Inc.
$34
Octapharma USA, Inc.
$32
Dendreon Pharmaceuticals LLC
$31
Epizyme, Inc.,
$30
TAIHO ONCOLOGY, INC.
$29
PUMA BIOTECHNOLOGY, INC.
$29
AMAG Pharmaceuticals, Inc.
$26
CTI BioPharma Corp.
$23
Servier Pharmaceuticals LLC
$23
Janssen Pharmaceuticals, Inc
$23
Helsinn Therapeutics (U.S.), Inc.
$22
Secura Bio, Inc.
$21
Acrotech Biopharma LLC
$20
Acceleron Pharma, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$18
Sun Pharmaceutical Industries Inc.
$18
Array BioPharma Inc.
$16
SpringWorks Therapeutics, Inc.
$16
Alnylam Pharmaceuticals Inc.
$16
Partner Therapeutics, Inc.
$16
Jazz Pharmaceuticals Inc.
$16
Pharmacosmos Therapeutics Inc.
$15
Progenics Pharmaceuticals, Inc.
$15
Clinigen Inc
$13
Sysmex Inostics Inc
$12
AbbVie, Inc.
$12
Fortovia Therapeutics, Inc.
$10
Top 3 companies account for 22.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AMS · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · Axonics · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Enhertu · Erleada · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · HYQVIA · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Proleukin · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Soltamox · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $10 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
19
Per 100K population
11.6
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Storey-Rojas is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Storey-Rojas experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Storey-Rojas performed 96,390 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Storey-Rojas receive payments from pharmaceutical companies?
Yes. Dr. Storey-Rojas received a total of $26,580 from 96 companies across 1,404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Storey-Rojas's costs compare to other hematology & oncology specialists in Vero Beach?
Dr. Storey-Rojas's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Storey-Rojas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Vero Beach
Browse hematology & oncology specialists in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology